Clinical Trial Update: Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy and safety of SYNB1618 and SYNB1934 in adults with phenylketonuria has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• SYNB1618 (SYNB1618)
• SYNB1934 (SYNB1934)

Snippet

Sponsor: Synlogic | Conditions: Phenylketonuria | Phase 2 | Status: COMPLETED